Behavioral cough therapy should be used as early intervention, said Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.
Behavioral cough therapy should be used as early intervention, said Laurie Slovarp, PhD, CCC-SLP, associate professor in the School of Speech, Language, Hearing, and Occupational Sciences at University of Montana.
Transcript
What is the benefit of using behavioral cough therapy in patients with chronic cough and using it early?
One of my passions is increasing awareness of this therapy, that it should be considered early. So most of these patients go through all kinds of tests and see several doctors before they come to see us. But my strong belief is that physicians should rule out anything serious, and there's ways to do that: chest X-ray and different tests. But once the serious things have been ruled out, if they have a dry cough, I think that they should try this therapy much, much sooner because it does improve their situation within a few weeks. And it takes longer than that, usually, to get in to see a specialist. And then the other thing is that, the data on patients that come to speech therapy are all patients that nothing else has really worked well for them, so they're already tricky patients. The data that we have shows that it is helpful. [It] doesn't mean the cough completely goes away, but it's helpful for 70 to 88% of patients, so the success rate is really quite high. In my own research, I did a huge survey study and over 50% said that they were quite satisfied that their cough was drastically improved after the therapy. So it's underutilized in my opinion, and it shouldn't be considered as a last resort, it should be considered more early intervention.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
August 11th 2025Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases.
Read More
Exploring the Potential of Machine Learning in Optimizing Respiratory Failure Treatment
August 9th 2025Machine learning holds promise for optimizing treatment strategies and potentially improving outcomes in respiratory failure but future research and development are necessary to fully realize its potential in clinical practice.
Read More
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More